Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | AKT2 |
| Upstream (Parents) |
|---|
| (<<) ADAM15 → AKT2 |
| (<<) EHD1 → AKT2 |
| (<<) ELF2 → AKT2 |
| (<<) FKSG2 → AKT2 |
| (<<) GNB5 → AKT2 |
| (<<) GSK3A → AKT2 |
| (<<) HEY1 → AKT2 |
| (<<) HIPK1 → AKT2 |
| (<<) HMGCS1 → AKT2 |
| (<<) MAPK14 → AKT2 |
| (<<) NFKBIB → AKT2 |
| (<<) PHOX2A → AKT2 |
| (<<) SALL2 → AKT2 |
| (<<) SLC29A1 → AKT2 |
| (<<) SRC → AKT2 |
| (<<) WNT3 → AKT2 |
| Downstream (Children) |
|---|
| AKT2 → CACNA1I (>>) |
| AKT2 → FOXO3 (>>) |
| AKT2 → ME1 (>>) |
| AKT2 → PTEN (>>) |
